Where does National Center FOR Global Health AND Medicine rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), National Center FOR Global Health AND Medicine ranks #26,937 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does National Center FOR Global Health AND Medicine hold?

National Center FOR Global Health AND Medicine holds 10 US utility patents granted between 2016 and 2025, spanning 11 technology areas.

What is National Center FOR Global Health AND Medicine's Innovation Score?

National Center FOR Global Health AND Medicine has an Innovation Score of 44.3 out of 100 (top 26% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is National Center FOR Global Health AND Medicine's patent grant rate increasing or decreasing?

National Center FOR Global Health AND Medicine's recent grant velocity is +100% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for National Center FOR Global Health AND Medicine's patents?

National Center FOR Global Health AND Medicine's patents average 7.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

National Center FOR Global Health AND Medicine

Q: What technology areas does National Center FOR Global Health AND Medicine focus on?

National Center FOR Global Health AND Medicine's top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 5 patents, ranking #1,801 of 4,144 assignees active in that subclass. Grants appear in 11 CPC subclasses total.

Q: How is the National Center FOR Global Health AND Medicine patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 10 granted patents across 11 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, National ranks #26,937 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 11 technology areas.

#26,937
of 49,997 US assignees by volume: Top 26%
by Innovation Score (44.3/100): 7.1
avg claims per patent: +100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R26937 · Foreign Corporation #26,937 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-SPARSE · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 10 grants
MID-PACK #26,937/49,997
PHOTO-FINISH Nanobrick
CPC-FOCUS C12N · 11 areas
INNOV-PAR 44.3/100
CLAIMS-SPARSE 7.1 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Nanobrick Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How National’s 44.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.3 pts (19%) Velocity 20.0 pts (45%) Breadth 11.7 pts (26%) Claim depth 4.3 pts (10%)

Qualcomm Incorporated · highest

85
National Center FOR… · this assignee

44
3D Lighting… · lowest

7

What this shows National's Innovation Score is 44.3/100 (top 26% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for National?

Each dot is one of National’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). National’s own 7.1 claims/patent is at or below the 12.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

National vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where National's grants concentrate

National Center FOR Global Health AND Medicine is a focused PatentsView assignee: 11 CPC subclasses with 50% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2022 (2 grants) versus a trough of 1 in 2016. By volume, National sits between Nanobrick Co., Ltd. and Neuvivo, Inc..

National's three-year grant acceleration

National Center FOR Global Health AND Medicine shows 5 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Nanobrick

10
Nanocarrier

10
Nantong Institute…

10
Napo Pharmaceutic…

10
National Disaster…

10
National Hospital…

10
Netlogic Microsys…

10
Neuvivo

10
National Center F… ◀

10

What this shows National holds 10 patents at rank #26,923, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near National

By rank, the assignees closest to #26,923 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in National's primary technology class.

National's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

44 Top 26% higher than 74% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

National Center FOR Global Health AND Medicine patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	10.0%
2017	1	10.0%
2018	1	10.0%
2021	1	10.0%
2022	2	20.0%
2023	1	10.0%
2024	2	20.0%
2025partial year	1	10.0%

Which technologies does National Center FOR Global Health AND Medicine patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 5

C07K - Peptides 5

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 3

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 3

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 2

C12Y - Enzymes 1

A61B - DIAGNOSIS; SURGERY; Identification 1

G06T - Image Data Processing OR Generation, IN General 1

A23K - Fodder 1

Y02A - Technologies FOR Adaptation TO Climate Change 1

C07D - Heterocyclic Compounds 1

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

National Center FOR Global Health AND Medicine's patent record in context - here's where to go next.

National Center FOR Global Health AND Medicine's lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 50% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #26,937 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare National Center FOR Global Health AND Medicine against Nanobrick Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 44.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.